Nutritional supplement to support immunity and energy in older adults
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This trial tests whether a safe nutrition supplement can help older adults with malnutrition maintain immune function and energy (mitochondrial function). It may support recovery during rehabilitation, but you must meet specific nutrition and health criteria.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 75 years or older
- You are starting or participating in a rehabilitation program
- You have malnutrition based on a screening score (MNA-SF below 11)
- You can understand the study and sign written consent
- You can take the provided nutrition supplement as instructed
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding appetite stimulants to a high-energy or high-protein drink can help older adults who have trouble eating enough. It aims to find a way to improve nutrition and appetite.
This trial tests an investigational drug called AMC6156 to see if it can help improve muscle mass and strength in older adults with sarcopenia (age-related muscle loss). Participants will also follow exercise and nutrition guidance.
This trial is testing a simple screening tool to identify malnutrition risk in adults visiting hospital clinics. Participating could help researchers find better ways to spot nutrition problems early and connect you with help.
This trial tests if taking leucine and omega-3 fatty acids can improve muscle mass and strength in older adults with low muscle health. It looks at people who have lost muscle and strength or walk slowly.
This study tests a personalized nutrition program for older adults to see if it can help maintain muscle strength and overall health. It looks at your grip strength, body mass index (BMI), where you live, and your cognitive ability.
This trial tests whether a sustained-release nicotinamide mononucleotide (NMN) supplement can improve immune aging and metabolism in people aged 50-70 who are overweight or have fatty liver, pre-diabetes, or mild type 2 diabetes.
Hear when a new Malnutrition trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.